Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma (American Journal of Clinical Dermatology, (2021), 22, 3, (407-414), 10.1007/s40257-021-00591-x)

Ellen J. Kim*, Joan Guitart, Christiane Querfeld, Michael Girardi, Amy Musiek, Oleg E. Akilov, James T. Angello, William L. Bailey, Larisa J. Geskin

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

A peer-reviewed infographic was retrospectively added to the original publication. The original article has been corrected.

Original languageEnglish (US)
JournalAmerican Journal of Clinical Dermatology
DOIs
StateAccepted/In press - 2022

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma (American Journal of Clinical Dermatology, (2021), 22, 3, (407-414), 10.1007/s40257-021-00591-x)'. Together they form a unique fingerprint.

Cite this